SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Anticipation around Alpha Taus oncology pipelineparticularly further REGAIN glioblastoma data after FDA clearance to expand the trial, alongside pancreatic and other study milestonesis driving attention. Many traders are optimistic about the early signals and upcoming catalysts, while others point to price consolidation and uncertainty about when the next concrete update will arrive.

Accenture is a global professional services company that helps the world’s businesses, governments and other organizations build their digital core, optimize their operations, accelerate revenue growth and enhance citizen services, creating tangible value at speed and scale. The firm combines technology and leadership in cloud, data and AI with industry experience, functional expertise and global delivery capability. Its services include Strategy & Consulting, Technology, Operations, Industry X, and Song. It operates through the following geographical segments: North America, EMEA, and Growth Markets. The company was founded in 1989 and is headquartered in Dublin, Ireland.

Accenture plc - Ordinary Shares - Class A

Traders are questioning whether Accenture can turn AI pilots into profitable, ongoing consulting work, with concerns that clients may delay follow-on projects if cost savings are unclear and that paused work could leave consultants underutilized. The debate is accompanied by unusual options and dark-pool activity, while traders disagree on the stocks technical direction.

Magnite, Inc. provides a technology solution to automate the purchase and sale of digital advertising inventory for buyers and sellers. It features applications and services for digital advertising sellers including websites, mobile applications, and other digital media properties. The company was founded by Frank Addante, Duc Chau, Craig Roah, Julie Mattern and Brian D. Baumgart on April 20, 2007 and is headquartered in New York, NY.

Magnite Inc

Strong quarterly results and a raised outlook, led by accelerating connected-TV advertising growth and expanding margins, are driving bullish attention around Magnite. Many traders see the performance as evidence of continued execution and potential upside, while others are taking profits or remain cautious about whether the stock can sustain its breakout.

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Vertex Pharmaceuticals, Inc.

Attention centers on the FDA decision for povetacicept in IgA nephropathy, with traders citing positive Phase 3 RAINIER results and debating its potential to establish a major kidney-disease franchise. The upcoming regulatory decision is viewed as a significant catalyst, while reactions to Vertexs latest earnings are mixed despite revenue growth and a higher outlook.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

Encouraging early zugocel results in autoimmune diseaseincluding clinical responses in five of six systemic-sclerosis patientshave drawn attention, with some traders emphasizing the reported safety profile while others caution that the data are preliminary and based on a small group. The conversation is also focused on the anticipated CTX310 cardiovascular-trial readout, seen as a second near-term pipeline catalyst.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is drawing attention amid a sharp energy-sector pullback as falling crude prices and hopes for U.S.Iran diplomacy unwind some of the war-related supply-risk premium. Traders disagree on whether the decline signals a lasting easing in oil risks or a buying opportunity, with bulls pointing to ongoing shipping and infrastructure disruptions and bears emphasizing weak charts and further downside risk.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Oktas quarterly results beat expectations and its raised outlook, alongside improving subscription backlog trends, fueled a sharp rally. Traders see AI-agent security as a growth opportunity, while skeptics question whether that demand can justify the valuation given the companys more modest core growth.

NRG Energy, Inc. engages in the production, sale, and distribution of energy and energy services. It operates through the following segments: Texas, East, West/Services/Other, Vivint Smart Home, and Corporate Activities. The Texas segment includes all activities related to customer, plant and market operations in Texas, other than Cottonwood. The East segment engages in all activities related to customer, plant and market operations in the East. The West/Services/Other segment is focused on all activities related to customer, plant and market operations in the West and Canada, and activities related to the Cottonwood facility and other investments. The Vivint Smart Home segment is a smart home platform that provides customers with technology, products and services to create a smarter, greener, safer home. The company was founded in 1989 and is headquartered in Houston, TX.

NRG Energy Inc.

NRG is drawing attention ahead of its earnings report, with traders pointing to unusual options and dark-pool activity and looking to Vistras strong results for clues about NRGs outlook. The debate centers on whether AI and data-center power demand can support growth, versus concerns about the timing of new load and pressure on electricity prices.

Zebec Network (ZBCN) is a cryptocurrency launched in 2022and operates on the Solana platform. Zebec Network has a current supply of 99,998,768,505.193803. The last known price of Zebec Network is 0.00179872 USD and is down -2.92 over the last 24 hours. It is currently trading on 133 active market(s) with $9,820,670.06 traded over the last 24 hours. More information can be found at https://zebec.io/.

Zebec Network

Zebecs reported payments and payroll developmentsincluding MoneyGram/Stellar connections, Robinhood Chain support, and a Germany-related deploymenthave fueled discussion about growing adoption. Bullish traders see these partnerships as potential catalysts, while skeptics argue that usage and token demand have yet to translate into sustained price strength.

Air Canada engages in the provision of airline transportation services. Its services cover full-service airline, scheduled passenger and cargo services, serving more than two hundred airports on six continents. It operates through the following geographical segments: Canada, U.S. Transborder, Atlantic, Pacific, and Other. The company was founded on April 11, 1936 and is headquartered in Saint-Laurent, Canada.

Air Canada Inc. - Ordinary Shares (Voting and Variable Voting)

Air Canada Inc.

Traders are focused on speculation that renewed conflict involving Iran could drive oil and jet-fuel costs higher, pressuring Air Canadas profitability and shares. Some expect further downside, while others point to the share-buyback program and the possibility of easing fuel costs as support.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
